Due: October 3, 2025 The purpose of this interagency program solicitation is to support the development of transformative high-risk, high-reward advances in computer and information science, engineering, mathematics, statistics, behavioral and/or cognitive research to address Read More
Due: October 3, 2025 Through this Notice of Funding Opportunity (NOFO), the National Cancer Institute (NCI) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies to improve the Read More
Due: October 1, 2025 This program supports a broad range of hypothesis-driven, multidisciplinary studies that have a short-term goal of advancing the state of the science in melanoma research and/or patient care. Team science is Read More
Due: October 17, 2025 The goal of this solicitation is to encourage small businesses to propose “out of the box” ideas to demonstrate “proof of concept” for the development of innovative technologies to make a Read More
Due: September 19, 2025 The purpose of this Notice of Funding Opportunity (NOFO) is to support a Human Tissue and Organ Research Resource program to enable the continued availability of human tissues and organs to Read More
Due: October 8, 2025 The Joint Program Executive Office for Chemical, Biological, Radiological, and Nuclear Defense (JPEO-CBRND) focused on surveying current industry capabilities in the engineering, testing, and manufacturing of solutions capable of neutralizing a Read More
Due: September 2, 2025 Preventative treatments and vaccines offer proactive solutions to biological threats: however, many of the current countermeasures are decades old. These prophylactic platforms have stagnated through single threat targeting which is potentiated Read More
Due: September 2, 2025 The Joint Science and Technology Office (JSTO) within the Defense Threat Reduction Agency (DTRA) supports the warfighter by developing medical countermeasures against a wide range of threats, including marine toxins. Exposure Read More
Due: August 4, 2025 The DxR2 program will solicit new point of care/remote-use products with domestic manufacturing capabilities which address test development for Public Health Emergency Medical Countermeasures Enterprise (PHEMCE) biothreats to include glanders, botulism, Read More
Due: December 15, 2025 The TechConnect Critical Technology Challenge: Biotech and Medical is a premier open innovation program designed to accelerate solutions to the most pressing challenges in biotechnology and medical innovation. Aligned with the critical technology Read More
NTA is operated by the 501c(3) non-profit Advanced Technology International (ATI). National Technology Alliance (NTA) © 2024 - All rights reserved.